Utility of albumin to creatinine ratio in screening for microalbuminuria among newly diagnosed diabetic patients in Uganda: a cross sectional study.


Journal

African health sciences
ISSN: 1729-0503
Titre abrégé: Afr Health Sci
Pays: Uganda
ID NLM: 101149451

Informations de publication

Date de publication:
Mar 2019
Historique:
entrez: 1 6 2019
pubmed: 1 6 2019
medline: 18 12 2019
Statut: ppublish

Résumé

The aim of this study was to determine the prevalence and factors associated with microalbuminuria among newly diagnosed diabetic patients in Mulago National Referral Hospital, Uganda. In this cross-sectional study conducted between June 2014 and January 2015, we collected information on patients' socio-demographics, biophysical profile, blood pressure, biochemical testing and echocardiographic findings using a pre-tested questionnaire. Bivariate and multivariate logistic regression analyses were used to investigate the association of several factors with microalbuminuria. Of the 175 patients recruited, males were 90(51.4%) and the mean age was 46±15 years. Majority of patients had type 2 DM 140 (80.0%) and the rest had type 1 DM 35 (20.0%). Mean glycated hemoglobin (HbA1C) was 13.9±5.3%. Mean duration of diabetes was 2 months. Prevalence of microalbuminuria was 47.4 % (95% CI: 40.0%-54.9%) overall. Pregnancy was associated with microalbuminuria (OR7.74[95%CI.1.01-76.47] P=0.050) while mild and moderate physical activity at work were inversely associated with microalbuminuria respectively (OR0.08[95%CI0.01-0.95] P=0.046) and (OR0.07[95%CI0.01-0.77] P=0.030). Prevalence of microalbuminuria was high in this group. Physical activity at work may be protective against microalbuminuria and this calls for longitudinal studies. Early detection and management of microalbuminuria in diabetics may slow progression to overt diabetic nephropathy (DN).

Sections du résumé

BACKGROUND BACKGROUND
The aim of this study was to determine the prevalence and factors associated with microalbuminuria among newly diagnosed diabetic patients in Mulago National Referral Hospital, Uganda.
METHODS METHODS
In this cross-sectional study conducted between June 2014 and January 2015, we collected information on patients' socio-demographics, biophysical profile, blood pressure, biochemical testing and echocardiographic findings using a pre-tested questionnaire. Bivariate and multivariate logistic regression analyses were used to investigate the association of several factors with microalbuminuria.
RESULTS RESULTS
Of the 175 patients recruited, males were 90(51.4%) and the mean age was 46±15 years. Majority of patients had type 2 DM 140 (80.0%) and the rest had type 1 DM 35 (20.0%). Mean glycated hemoglobin (HbA1C) was 13.9±5.3%. Mean duration of diabetes was 2 months. Prevalence of microalbuminuria was 47.4 % (95% CI: 40.0%-54.9%) overall. Pregnancy was associated with microalbuminuria (OR7.74[95%CI.1.01-76.47] P=0.050) while mild and moderate physical activity at work were inversely associated with microalbuminuria respectively (OR0.08[95%CI0.01-0.95] P=0.046) and (OR0.07[95%CI0.01-0.77] P=0.030).
CONCLUSION CONCLUSIONS
Prevalence of microalbuminuria was high in this group. Physical activity at work may be protective against microalbuminuria and this calls for longitudinal studies. Early detection and management of microalbuminuria in diabetics may slow progression to overt diabetic nephropathy (DN).

Identifiants

pubmed: 31148990
doi: 10.4314/ahs.v19i1.36
pii: jAFHS.v19.i1.pg1607
pmc: PMC6531967
doi:

Substances chimiques

Biomarkers 0
Glycated Hemoglobin A 0
Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1607-1616

Références

J Pediatr Endocrinol Metab. 1999 Mar-Apr;12(2):185-92
pubmed: 10392365
Lancet. 1999 Jul 31;354(9176):359-64
pubmed: 10437863
JAMA. 2001 Jul 25;286(4):421-6
pubmed: 11466120
N Engl J Med. 2003 Jun 5;348(23):2285-93
pubmed: 12788992
Diabetes Care. 2003 Aug;26(8):2389-91
pubmed: 12882867
Diabetes Care. 2004 Jan;27 Suppl 1:S79-83
pubmed: 14693934
BMJ. 2004 May 8;328(7448):1105
pubmed: 15096438
Kidney Int. 1992 Apr;41(4):758-62
pubmed: 1513098
Kidney Int Suppl. 2004 Nov;(92):S32-7
pubmed: 15485413
Kidney Int. 2004 Dec;66(6):2109-18
pubmed: 15569300
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
Hypertension. 2006 Nov;48(5):832-3
pubmed: 17015769
Indian J Nephrol. 2009 Apr;19(2):53-6
pubmed: 20368924
Diabet Med. 2010 May;27(5):532-7
pubmed: 20536948
Lancet. 2010 Jun 26;375(9733):2254-66
pubmed: 20609971
Mayo Clin Proc. 2011 May;86(5):444-56
pubmed: 21531886
PLoS One. 2012;7(5):e36718
pubmed: 22590593
Afr Health Sci. 2012 Jun;12(2):140-7
pubmed: 23056019
Eur J Med Res. 2013 Feb 22;18:4
pubmed: 23432977
Heart. 2013 Jul;99(14):979-83
pubmed: 23680891
Adv Chronic Kidney Dis. 2014 May;21(3):260-6
pubmed: 24780453
J Diabetes Res. 2014;2014:394206
pubmed: 25587544
Ann Pediatr Endocrinol Metab. 2015 Mar;20(1):13-20
pubmed: 25883922
World J Diabetes. 2015 Jun 10;6(5):759-73
pubmed: 26069725
Saudi J Kidney Dis Transpl. 2018 May-Jun;29(3):649-657
pubmed: 29970743
JNMA J Nepal Med Assoc. 2018 Jan-Feb;56(209):516-521
pubmed: 30058635
BMC Res Notes. 2018 Aug 06;11(1):565
pubmed: 30081966
Mymensingh Med J. 2018 Jul;27(3):467-474
pubmed: 30141433
Am J Med. 1985 May;78(5):785-94
pubmed: 3993659
Lancet. 1995 Oct 21;346(8982):1080-4
pubmed: 7564792

Auteurs

Martin Muddu (M)

Department of Medicine Makerere University College of Health Sciences, Mulago Hospital Complex.

Edrisa Mutebi (E)

Department of Medicine Makerere University College of Health Sciences, Mulago Hospital Complex.

Isaac Ssinabulya (I)

Department of Medicine Makerere University College of Health Sciences, Mulago Hospital Complex.

Samuel Kizito (S)

Clinical Epidemiology Unit, Makerere University College of Health Sciences.

Frank Mulindwa (F)

Department of Medicine Makerere University College of Health Sciences, Mulago Hospital Complex.

Charles Mondo Kiiza (CM)

Department of Medicine Makerere University College of Health Sciences, Mulago Hospital Complex.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH